Manuel Méndez Muñiz

Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland.

The Latino Corporate Directors Association (LCDA) advocates for greater representation of Latinx individuals in corporate governance to promote diversity and inclusion. The private company is based in Washington. The American company's mission is to advance multicultural boardrooms that promote equity and corporate social responsibility. The company was founded in 2013 by Patricia Salas Pineda. The CEO is Ozzie Gromada Meza.

Part of Quotient Ltd., Quotient Suisse SA is a diagnostics company based in Eysins, Switzerland. The Swiss company prioritizes the health of patients by creating innovative solutions for faster disease detection to shorten the time to diagnosis. The company's transfusion portfolio, Alba, and their clinical diagnostics solution, Mosaiq, are designed to make laboratories more efficient and clinical decision-making more effective. Alivedx, formerly known as Alba Bioscience and Quotient, empowers diagnostic insights, transforms patient care, and innovates for life. The company's products include blood bank reagents, Alba, and Mosaiq, the world's first automated testing platform.